Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111377867B discloses a novel route for 2-(1-alkyl-1H-pyrazol-4-yl)morpholine. Enables cost reduction in kinase inhibitor manufacturing with scalable, mild conditions.
Patent CN1166672C details a novel Ru-H4-BINAP-diamine complex for asymmetric hydrogenation, offering high enantioselectivity and cost-effective manufacturing for chiral alcohol intermediates.
Patent CN114292227A reveals a low-pressure fluorination route for 2-chloro-3-trifluoromethylpyridine. Achieve high purity and cost reduction in agrochemical intermediate manufacturing.
This patent details a novel silver-catalyzed route for 3-isocoumarin-based chromones, offering mild conditions and high yields for scalable pharmaceutical intermediate manufacturing.
Patent CN112010913B reveals a scalable MgCl2-mediated demethylation for 4-deoxy daunorubicin intermediates, offering reduced impurities and enhanced supply chain reliability for pharmaceutical manufacturers.
Patent CN102978267B reveals advanced enzymatic glutathione production with ATP regeneration. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN112961054A reveals a scalable iron-catalyzed method for aromatic difluoromethylation, offering cost-effective routes for high-purity pharmaceutical intermediates.
Novel iodination route for Crisaborole key intermediate reduces EHS risks and improves yield. Ideal for reliable pharmaceutical intermediate supplier partnerships.
Patent CN116023280A reveals a high-yield synthesis method for 2-amino-4-nitrophenol using polysulfide reduction offering significant supply chain and cost advantages for industrial buyers.
Patent CN114075258B reveals a novel iodine-free route for hydrocortisone production, offering superior purity over 99.5% and streamlined manufacturing for global supply chains.
Advanced process for 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one using Mg-Reformatsky and Ru-catalysis. Delivers cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102060780A details a high-yield synthesis of 2-aminobenzimidazole derivatives, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN109384789A enables room temperature synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally. Offers green chemistry solutions.
Novel (R)-ω-transaminase mutant enables high-conversion synthesis of Sitagliptin intermediates, offering cost-effective and scalable pharmaceutical manufacturing solutions.
Patent CN107641622B reveals efficient enzymatic hydrolysis of terephthalonitrile, offering cost reduction in pharmaceutical intermediate manufacturing with high substrate tolerance.
Patent CN107384887A reveals high-purity Sitagliptin synthesis via aminotransferase. Achieves 99% ee and 76% yield, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN111411094B discloses a novel mutant enzyme achieving 95.4% conversion at high substrate concentrations, offering significant cost reduction in API manufacturing.
Patent CN108866021B details a novel transaminase mutant for synthesizing sitagliptin intermediates with >99% ee. Discover cost-effective biocatalytic solutions for API manufacturing.
Novel preparation method for Arotinolol Hydrochloride via CN112300149A. Achieves high purity and cost reduction in pharmaceutical intermediates manufacturing through one-pot coupling.
Novel omega-aminotransferase mutant enables high-yield sitagliptin intermediate production with 99% ee value and reduced solvent constraints for global supply chains.